382 related articles for article (PubMed ID: 34075584)
1. Cancer-associated fibroblasts: Key players in shaping the tumor immune microenvironment.
Desbois M; Wang Y
Immunol Rev; 2021 Jul; 302(1):241-258. PubMed ID: 34075584
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast diversity and plasticity in the tumor microenvironment: roles in immunity and relevant therapies.
Xu Y; Li W; Lin S; Liu B; Wu P; Li L
Cell Commun Signal; 2023 Sep; 21(1):234. PubMed ID: 37723510
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated fibroblasts: Versatile mediators in remodeling the tumor microenvironment.
Zhang Q; Wang Y; Liu F
Cell Signal; 2023 Mar; 103():110567. PubMed ID: 36538999
[TBL] [Abstract][Full Text] [Related]
4. Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials.
Zhang H; Yue X; Chen Z; Liu C; Wu W; Zhang N; Liu Z; Yang L; Jiang Q; Cheng Q; Luo P; Liu G
Mol Cancer; 2023 Oct; 22(1):159. PubMed ID: 37784082
[TBL] [Abstract][Full Text] [Related]
5. From gatekeepers to providers: regulation of immune functions by cancer-associated fibroblasts.
Arpinati L; Scherz-Shouval R
Trends Cancer; 2023 May; 9(5):421-443. PubMed ID: 36870916
[TBL] [Abstract][Full Text] [Related]
6. CAFs orchestrates tumor immune microenvironment-A new target in cancer therapy?
Zhang C; Fei Y; Wang H; Hu S; Liu C; Hu R; Du Q
Front Pharmacol; 2023; 14():1113378. PubMed ID: 37007004
[TBL] [Abstract][Full Text] [Related]
7. Targeting cancer-associated fibroblasts: Challenges, opportunities and future directions.
Jenkins BH; Buckingham JF; Hanley CJ; Thomas GJ
Pharmacol Ther; 2022 Dec; 240():108231. PubMed ID: 35718294
[TBL] [Abstract][Full Text] [Related]
8. Targeting CAFs to overcome anticancer therapeutic resistance.
Saw PE; Chen J; Song E
Trends Cancer; 2022 Jul; 8(7):527-555. PubMed ID: 35331673
[TBL] [Abstract][Full Text] [Related]
9. Transcription factors in fibroblast plasticity and CAF heterogeneity.
Melchionna R; Trono P; Di Carlo A; Di Modugno F; Nisticò P
J Exp Clin Cancer Res; 2023 Dec; 42(1):347. PubMed ID: 38124183
[TBL] [Abstract][Full Text] [Related]
10. The Origin, Differentiation, and Functions of Cancer-Associated Fibroblasts in Gastrointestinal Cancer.
Huang J; Tsang WY; Li ZH; Guan XY
Cell Mol Gastroenterol Hepatol; 2023; 16(4):503-511. PubMed ID: 37451403
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in cancer-associated fibroblast: Biomarkers, signaling pathways, and therapeutic opportunities.
Zhou D; Zheng L
Chin Med J (Engl); 2024 Mar; 137(6):638-650. PubMed ID: 38420743
[TBL] [Abstract][Full Text] [Related]
12. Dissecting the role of cancer-associated fibroblast-derived biglycan as a potential therapeutic target in immunotherapy resistance: A tumor bulk and single-cell transcriptomic study.
Zheng S; Liang JY; Tang Y; Xie J; Zou Y; Yang A; Shao N; Kuang X; Ji F; Liu X; Tian W; Xiao W; Lin Y
Clin Transl Med; 2023 Feb; 13(2):e1189. PubMed ID: 36772945
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated fibroblasts: Just on the opposite side of antitumour immunity?
Guo S; Yuan J; Meng X; Feng X; Ma D; Han Y; Li K
Int Immunopharmacol; 2023 Sep; 122():110601. PubMed ID: 37418988
[TBL] [Abstract][Full Text] [Related]
14. CAF-immune cell crosstalk and its impact in immunotherapy.
Maia A; Schöllhorn A; Schuhmacher J; Gouttefangeas C
Semin Immunopathol; 2023 Mar; 45(2):203-214. PubMed ID: 36480035
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of Cancer-Associated Fibroblasts and the Tumor Immune Microenvironment in Pancreatic Cancer.
Shinkawa T; Ohuchida K; Nakamura M
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010986
[TBL] [Abstract][Full Text] [Related]
16. Nano-Drug Delivery Systems Targeting CAFs: A Promising Treatment for Pancreatic Cancer.
Wang M; Xue W; Yuan H; Wang Z; Yu L
Int J Nanomedicine; 2024; 19():2823-2849. PubMed ID: 38525013
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk between the nervous system and tumor microenvironment: Functional aspects and potential therapeutic strategies.
Wang L; Ge J; Han H; Jia Y; Qin Y
Cancer Lett; 2024 Jul; 594():216986. PubMed ID: 38797233
[TBL] [Abstract][Full Text] [Related]
18. Intimate communications within the tumor microenvironment: stromal factors function as an orchestra.
Cheng B; Yu Q; Wang W
J Biomed Sci; 2023 Jan; 30(1):1. PubMed ID: 36600243
[TBL] [Abstract][Full Text] [Related]
19. Cancer-associated fibroblasts: tumor defenders in radiation therapy.
Zhang Y; Lv N; Li M; Liu M; Wu C
Cell Death Dis; 2023 Aug; 14(8):541. PubMed ID: 37607935
[TBL] [Abstract][Full Text] [Related]
20. Unlocking the potential of the tumor microenvironment for cancer therapy.
Tufail M
Pathol Res Pract; 2023 Nov; 251():154846. PubMed ID: 37837860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
